State of Wisconsin Investment Board’s Tourmaline Bio TRML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-19,822
Closed -$317K 2526
2025
Q2
$317K Buy
19,822
+900
+5% +$14.6K ﹤0.01% 2044
2025
Q1
$288K Buy
18,922
+1,129
+6% +$18.1K ﹤0.01% 1980
2024
Q4
$361K Buy
+17,793
New +$448K ﹤0.01% 1940
2024
Q3
Sell
-11,686
Closed -$150K 2366
2024
Q2
$150K Sell
11,686
-297
-2% -$4.78K ﹤0.01% 2186
2024
Q1
$274K Buy
+11,983
New +$423K ﹤0.01% 1976
2022
Q2
Sell
-1,150
Closed -$113K 2873
2022
Q1
$113K Hold
1,150
﹤0.01% 2215
2021
Q4
$176K Hold
1,150
﹤0.01% 2098
2021
Q3
$156K Buy
+1,150
New +$157K ﹤0.01% 2089

Other funds holding TRML

State of Wisconsin Investment Board's TRML Position: Q3 2025 in Review

State of Wisconsin Investment Board sold out of Tourmaline Bio (TRML) in Q3 2025, closing a stake of 19,822 shares — an estimated $317K sold.

State of Wisconsin Investment Board first reported a position in TRML in Q3 2021 and held it in 8 quarters. The position peaked at $361K in Q4 2024. 134 funds tracked by Wall St. Rank hold TRML as of Q3 2025.

  • State of Wisconsin Investment Board reported no remaining Tourmaline Bio position as of Q3 2025 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 19,822 Tourmaline Bio shares in Q3 2025, an estimated $317K.
  • State of Wisconsin Investment Board first reported a position in Tourmaline Bio in Q3 2021 and held it in 8 quarters.
  • State of Wisconsin Investment Board's Tourmaline Bio position peaked at $361K in Q4 2024.
  • 134 funds tracked by Wall St. Rank held Tourmaline Bio as of Q3 2025.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2025, filed 14 Nov 2025.